Thermo Fisher Scientific Inc. Ranks 80th in Trading Volume Despite 5-Day Stock Price Surge

On June 12, 2025, Thermo Fisher Scientific Inc. (TMO) saw a trading volume of $856 million, a 32.9% decrease from the previous day, ranking 80th in the day's stock market activity. The stock price rose by 0.04%, marking the fifth consecutive day of gains, with a total increase of 4.26% over the past five days.

Thermo Fisher Scientific recently unveiled its next-generation mass spectrometers at the ASMS 2025 conference, aiming to revolutionize biopharmaceutical applications and omics research. This announcement highlights the company's commitment to advancing scientific innovation and improving research capabilities in the biopharma sector.

The Regeneron Genetics Center has chosen Thermo Fisher Scientific's Olink Explore HT proteomics platform for a large-scale investigation involving nearly 200,000 patient samples from the Geisinger Health Study. This project aims to uncover new insights into human disease mechanisms and validate genetic hypotheses, potentially leading to the discovery of novel disease biomarkers and improved drug development efficiencies.

The selection of Olink Explore HT for this ambitious endeavor underscores its unparalleled scalability, high throughput, and superior specificity, making it an ideal choice for processing a vast number of samples. This initiative represents a significant milestone in the field of proteomics, paving the way for future studies to advance our understanding of human health and disease.